<DOC>
	<DOCNO>NCT00461357</DOCNO>
	<brief_summary>The Eurotransplant Senior Program ( ESP ) start 1999 local allocation kidney decease donor elder 65 year recipient elder 65 year . The requirement immunosuppression group patient high due large amount comorbidities . This prospective randomize trial compare standard immunosuppressive protocol base cyclosporine A ( CyA ) use center within ESP , calcineurin inhibitor-free protocol base sirolimus ( SRL ) . The aim study investigate effect CNI-free therapy function elderly kidney 6 month post transplantation , measure GFR .</brief_summary>
	<brief_title>Sirolimus Based Immunosuppression Patients Undergoing Kidney Transplantation Eurotransplant Senior Program</brief_title>
	<detailed_description />
	<criteria>Recipients Eurotransplant Senior Program negative cytotoxic crossmatch sign informed consent High sensitize recipient ( PRA &gt; 40 % ) Non heart Beating Donor Hyperlipidemia Leucocytopenia ( &lt; 3000/mm3 ) Thrombocytopenia ( &lt; 75000/mm3 )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Old Old</keyword>
	<keyword>Eurotransplant Senior Program</keyword>
	<keyword>Glomerular Filtration Rate</keyword>
</DOC>